LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-31,06 % | 9,3 Mrd. | |
-8,43 % | 3,1 Mrd. | |
+27,31 % | 2,87 Mrd. | |
-14,31 % | 2,17 Mrd. | |
-18,94 % | 1,75 Mrd. | |
+73,13 % | 1,5 Mrd. | |
+30,25 % | 807 Mio. | |
-1,97 % | 759 Mio. | |
-26,73 % | 532 Mio. |